631 related articles for article (PubMed ID: 27332619)
1. State Legal Restrictions and Prescription-Opioid Use among Disabled Adults.
Meara E; Horwitz JR; Powell W; McClelland L; Zhou W; O'Malley AJ; Morden NE
N Engl J Med; 2016 Jul; 375(1):44-53. PubMed ID: 27332619
[TBL] [Abstract][Full Text] [Related]
2. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
3. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.
Rutkow L; Chang HY; Daubresse M; Webster DW; Stuart EA; Alexander GC
JAMA Intern Med; 2015 Oct; 175(10):1642-9. PubMed ID: 26280092
[TBL] [Abstract][Full Text] [Related]
4. Protocol: mixed-methods study to evaluate implementation, enforcement, and outcomes of U.S. state laws intended to curb high-risk opioid prescribing.
McGinty EE; Stuart EA; Caleb Alexander G; Barry CL; Bicket MC; Rutkow L
Implement Sci; 2018 Feb; 13(1):37. PubMed ID: 29482599
[TBL] [Abstract][Full Text] [Related]
5. Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States.
Moyo P; Simoni-Wastila L; Griffin BA; Onukwugha E; Harrington D; Alexander GC; Palumbo F
Addiction; 2017 Oct; 112(10):1784-1796. PubMed ID: 28498498
[TBL] [Abstract][Full Text] [Related]
6. High-risk use by patients prescribed opioids for pain and its role in overdose deaths.
Gwira Baumblatt JA; Wiedeman C; Dunn JR; Schaffner W; Paulozzi LJ; Jones TF
JAMA Intern Med; 2014 May; 174(5):796-801. PubMed ID: 24589873
[TBL] [Abstract][Full Text] [Related]
7. Dual Receipt of Prescription Opioids From the Department of Veterans Affairs and Medicare Part D and Prescription Opioid Overdose Death Among Veterans: A Nested Case-Control Study.
Moyo P; Zhao X; Thorpe CT; Thorpe JM; Sileanu FE; Cashy JP; Hale JA; Mor MK; Radomski TR; Donohue JM; Hausmann LRM; Hanlon JT; Good CB; Fine MJ; Gellad WF
Ann Intern Med; 2019 Apr; 170(7):433-442. PubMed ID: 30856660
[TBL] [Abstract][Full Text] [Related]
8. The Prevalence and Cost of Medicare Beneficiaries Diagnosed and At Risk for Opioid Abuse, Dependence, and Poisoning.
Roland CL; Ye X; Stevens V; Oderda GM
J Manag Care Spec Pharm; 2019 Jan; 25(1):18-27. PubMed ID: 30589633
[TBL] [Abstract][Full Text] [Related]
9. The effects of state rules on opioid prescribing in Indiana.
Al Achkar M; Grannis S; Revere D; MacKie P; Howard M; Gupta S
BMC Health Serv Res; 2018 Jan; 18(1):29. PubMed ID: 29347984
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of New Opioid Use Among Medicare Beneficiaries: Identifying High-Risk Patterns.
Raman SR; Bush C; Karmali RN; Greenblatt LH; Roberts AW; Skinner AC
J Manag Care Spec Pharm; 2019 Sep; 25(9):966-972. PubMed ID: 31456497
[TBL] [Abstract][Full Text] [Related]
11. Opioid Prescribing Behaviors - Prescription Behavior Surveillance System, 11 States, 2010-2016.
Strickler GK; Kreiner PW; Halpin JF; Doyle E; Paulozzi LJ
MMWR Surveill Summ; 2020 Jan; 69(1):1-14. PubMed ID: 31999681
[TBL] [Abstract][Full Text] [Related]
12. Opioid Prescribing Patterns and Patient Outcomes by Prescriber Type in the Oregon Prescription Drug Monitoring Program.
Fink PB; Deyo RA; Hallvik SE; Hildebran C
Pain Med; 2018 Dec; 19(12):2481-2486. PubMed ID: 29155988
[TBL] [Abstract][Full Text] [Related]
13. Prescription opioid use among disabled Medicare beneficiaries: intensity, trends, and regional variation.
Morden NE; Munson JC; Colla CH; Skinner JS; Bynum JP; Zhou W; Meara E
Med Care; 2014 Sep; 52(9):852-9. PubMed ID: 25119955
[TBL] [Abstract][Full Text] [Related]
14. Prescription opioid misuse in the United States and the United Kingdom: cautionary lessons.
Weisberg DF; Becker WC; Fiellin DA; Stannard C
Int J Drug Policy; 2014 Nov; 25(6):1124-30. PubMed ID: 25190034
[TBL] [Abstract][Full Text] [Related]
15. Assessing The Impact Of State Policies For Prescription Drug Monitoring Programs On High-Risk Opioid Prescriptions.
Bao Y; Wen K; Johnson P; Jeng PJ; Meisel ZF; Schackman BR
Health Aff (Millwood); 2018 Oct; 37(10):1596-1604. PubMed ID: 30273045
[TBL] [Abstract][Full Text] [Related]
16. Opioid Prescribing Among Adults With Disabilities in the United States After the 2014 Federal Hydrocodone Rescheduling Regulation.
Liaw V; Kuo YF; Raji MA; Baillargeon J
Public Health Rep; 2020 Jan; 135(1):114-123. PubMed ID: 31835012
[TBL] [Abstract][Full Text] [Related]
17. Racial Inequality in Prescription Opioid Receipt - Role of Individual Health Systems.
Morden NE; Chyn D; Wood A; Meara E
N Engl J Med; 2021 Jul; 385(4):342-351. PubMed ID: 34289277
[TBL] [Abstract][Full Text] [Related]
18. Patterns of Potential Opioid Misuse and Subsequent Adverse Outcomes in Medicare, 2008 to 2012.
Carey CM; Jena AB; Barnett ML
Ann Intern Med; 2018 Jun; 168(12):837-845. PubMed ID: 29800019
[TBL] [Abstract][Full Text] [Related]
19. Patterns of abuse among unintentional pharmaceutical overdose fatalities.
Hall AJ; Logan JE; Toblin RL; Kaplan JA; Kraner JC; Bixler D; Crosby AE; Paulozzi LJ
JAMA; 2008 Dec; 300(22):2613-20. PubMed ID: 19066381
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors of Prescription Opioid Overdose Among Colorado Medicaid Beneficiaries.
Dilokthornsakul P; Moore G; Campbell JD; Lodge R; Traugott C; Zerzan J; Allen R; Page RL
J Pain; 2016 Apr; 17(4):436-43. PubMed ID: 26721613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
